Comparison of location, severity, and dose response of proximal axonal lesions induced by 3,3'-iminodipropionitrile and deuterium substituted analogs
- PMID: 1484287
- DOI: 10.1097/00005072-199211000-00001
Comparison of location, severity, and dose response of proximal axonal lesions induced by 3,3'-iminodipropionitrile and deuterium substituted analogs
Abstract
Administration of 3,3'-iminodipropionitrile (IDPN) to rats results in massive accumulation of tangled neurofilaments in the proximal axons of large neurons, such as in dorsal root ganglia (DRG) and ventral horns of the lumbar spinal cord (LSC). Clinically, rats develop hyperexcitability, circling, head bobbing, and retropulsion. The ultimate toxicant and the molecular mechanism are not known. In a study designed to explore potential activation and detoxification pathways, dose-related differences in location and severity of lesions were observed in rats treated with IDPN or deuterium substituted analogs, 2,2,2',2'-tetradeuterio-IDPN (2-d-IDPN) or 3,3,3',3'-tetradeuterio-IDPN (3-d-IDPN). The compounds or saline were administered intraperitoneally to three rats per group at dose levels of 3.0, 1.5, 1.0, and 0.0 mmole/kg/day for 3 days. One week after the initial dose, tissues from DRG and LSC were collected, prepared and evaluated histologically in zones extending from areas adjacent to the cell bodies, distally toward the DRG stalk or toward the lumbar spinal roots. In the low dose IDPN group, DRG and LSC lesions were most prominent in distal zones. As dosage increased, the lesions progressed in severity and in proximity to the cell bodies. At the high dose, lesions were prominent in all zones. The same general pattern occurred with both analogs, although 2-d-IDPN was less potent than IDPN and 3-d-IDPN was more potent than IDPN. The differences in potency from the secondary isotopic effect of deuterium suggest that the 3-position is important in detoxification while the 2-position is important in the bioactivation of IDPN.
Similar articles
-
Metabolism of 3,3'-iminodipropionitrile and deuterium-substituted analogs: potential mechanisms of detoxification and activation.Toxicol Appl Pharmacol. 1994 Jan;124(1):59-66. doi: 10.1006/taap.1994.1008. Toxicol Appl Pharmacol. 1994. PMID: 8291062
-
Comparison of behavioral, vestibular, and axonal effects of subchronic IDPN in the rat.Neurotoxicol Teratol. 1997 Mar-Apr;19(2):117-27. doi: 10.1016/s0892-0362(96)00216-4. Neurotoxicol Teratol. 1997. PMID: 9136128
-
Exacerbation of iminodipropionitrile-induced behavioral toxicity, oxidative stress, and vestibular hair cell degeneration by gentamicin in rats.Neurotoxicol Teratol. 2000 Mar-Apr;22(2):213-20. doi: 10.1016/s0892-0362(99)00075-6. Neurotoxicol Teratol. 2000. PMID: 10758350
-
Cysteamine attenuates iminodipropionitrile (IDPN) induced dyskinesia in rats.Int J Neurosci. 1995 Dec;83(3-4):165-75. doi: 10.3109/00207459508986336. Int J Neurosci. 1995. PMID: 8869425 Review.
-
The pathophysiology of proximal neurofilamentous giant axonal swellings: implications for the pathogenesis of amyotrophic lateral sclerosis.Toxicology. 1987 Oct 30;46(2):125-39. doi: 10.1016/0300-483x(87)90123-5. Toxicology. 1987. PMID: 3313811 Review.
Cited by
-
Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis (ALS). Clinical studies in ALS of Guam and experimental studies in deafferented neurons and in beta,beta'-iminodipropionitrile axonopathy.Am J Pathol. 1994 Jun;144(6):1288-300. Am J Pathol. 1994. PMID: 8203467 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials